The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6
Open accessAbstract
Background & aims Stearoyl-CoA desaturase (SCD) synthesizes monounsaturated fatty acids (MUFAs) and has been associated with the development of metabolic syndrome, tumorigenesis, and stem cell characteristics. We investigated whether and how SCD promotes liver fibrosis and tumor development in mice.Methods Rodent primary hepatic stellate cells (HSCs), mouse liver tumor-initiating stem cell-like cells (TICs), and human hepatocellular carcinoma (HCC) cell lines were exposed to Wnt signaling inhibitors and changes in gene expression patterns were analyzed. We assessed the functions of SCD by pharmacologic and conditional genetic manipulation in mice with hepatotoxic or cholestatic induction of liver fibrosis, orthotopic transplants of TICs, or liver tumors induced by administration of diethyl nitrosamine. We performed bioinformatic analyses of SCD expression in HCC vs nontumor liver samples collected from patients, and correlated levels with HCC stage and patient mortality. We performed nano-bead pull-down assays, liquid chromatography-mass spectrometry, computational modeling, and ribonucleoprotein immunoprecipitation analyses to identify MUFA-interacting proteins. We examined the effects of SCD inhibition on Wnt signaling, including the expression and stability of low-density lipoprotein-receptor-related proteins 5 and 6 (LRP5 and LRP6), by immunoblot and quantitative polymerase chain reaction analyses.Results SCD was overexpressed in activated HSC and HCC cells from patients; levels of SCD messenger RNA (mRNA) correlated with HCC stage and patient survival time. In rodent HSCs and TICs, the Wnt effector β-catenin increased sterol regulatory element binding protein 1-dependent transcription of Scd, and β-catenin in return was stabilized by MUFAs generated by SCD. This loop required MUFA inhibition of binding of Ras-related nuclear protein 1 (Ran1) to transportin 1 and reduced nuclear import of elav-like protein 1 (HuR), increasing cytosolic levels of HuR and HuR-mediated stabilization of mRNAs encoding LRP5 and LRP6. Genetic disruption of Scd and pharmacologic inhibitors of SCD reduced HSC activation and TIC self-renewal and attenuated liver fibrosis and tumorigenesis in mice. Conditional disruption of Scd2 in activated HSCs prevented growth of tumors from TICs and reduced the formation of diethyl nitrosamine-induced liver tumors in mice.Conclusions In rodent HSCs and TICs, we found SCD expression to be regulated by Wnt-β-catenin signaling, and MUFAs produced by SCD provided a forward loop to amplify Wnt signaling via stabilization of Lrp5 and Lrp6 mRNAs, contributing to liver fibrosis and tumor growth. SCD expressed by HSCs promoted liver tumor development in mice. Components of the identified loop linking HSCs and TICs might be therapeutic targets for liver fibrosis and tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The selective inhibition of stearoyl-CoA desaturase 1 in HSCs reduced their activation and inhibited fibrosis in rodent models.120”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells
Chen, C., Tsukamoto, H., Liu, J.-C., Kashiwabara, C., Feldman, D. E., Sher, L. S., Dooley, S., French, S. W., Mishra, L., Petrovic, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65859 · Cited by 161
Self-citationRetractedAutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 26,294
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,587
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J. R., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11211 · Cited by 1,102
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
Self-citationβ-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Monga, S. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.056 · Cited by 493
He, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S. E., Jepsen, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.031 · Cited by 476
miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop
Kapinas, K., Kessler, C. B., Ricks, T., Gronowicz, G., & Delany, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116137 · Cited by 405
Cited by
Sorted by citations
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Self-citationMetabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 665
Wnt–β-catenin signalling in liver development, health and disease
Perugorria, M. J., Olaizola, P., Labiano, I., Esparza-Baquer, A., Marzioni, M., Marín, J. J. G., Bujanda, L., & Bañales, J. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0075-9 · Cited by 622
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
Lee, T. K., Guan, X., & Ma, S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00508-3 · Cited by 463
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Multi-organ proteomic landscape of COVID-19 autopsies
Nie, X., Qian, L., Sun, R., Huang, B., Dong, X., Xiao, Q., Zhang, Q., Lu, T., Yue, L., Chen, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.004 · Cited by 403
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
Emerging role of lipid metabolism alterations in Cancer stem cells
Yi, M., Li, J., Chen, S., Cai, J., Ban, Y., Peng, Q., Zhou, Y., Zeng, Z., Peng, S., Li, X., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0784-5 · Cited by 253
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
Tracz‐Gaszewska, Z., & Dobrzyń, P. (2019) · Cancers · doi:10.3390/cancers11070948 · Cited by 253
Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
Nenkov, M., Ma, Y., Gaßler, N., & Chen, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126262 · Cited by 226
The role of YAP/TAZ activity in cancer metabolic reprogramming
Zhang, X., Zhao, H., Li, Y., Xia, D., Yang, L., Ma, Y., & Li, H. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0882-1 · Cited by 212
Wnt signaling pathway in aging-related tissue fibrosis and therapies
Hu, H.-H., Cao, G., Wu, X., Vaziri, N. D., & Zhao, Y. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101063 · Cited by 196
Piccinin, E., Cariello, M., Santis, S. D., Ducheix, S., Sabbà, C., Ntambi, J. M., & Moschetta, A. (2019) · Nutrients · doi:10.3390/nu11102283 · Cited by 196
Self-citationDong, W., Dai, Z., Liu, F., Guo, X., Ge, C.-M., Ding, J., Liu, H., & Yang, F. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.030 · Cited by 178
Ma, M. K. F., Lau, E. Y.-T., Leung, H.-W., Lo, J. H. T., Ho, N. P. Y., Cheng, L. K., Ma, S., Lin, C. H., Copland, J. A., Ding, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.015 · Cited by 178
Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
Nakagawa, H., Hayata, Y., Kawamura, S., Yamada, T., Fujiwara, N., & Koike, K. (2018) · Cancers · doi:10.3390/cancers10110447 · Cited by 176
Ahmed, N., Escalona, R. M., Leung, D. T. H., Chan, E., & Kannourakis, G. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.10.002 · Cited by 166
Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Li, H., Feng, Z., & He, M. (2020) · Theranostics · doi:10.7150/thno.41388 · Cited by 161
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Jagušt, P., de Luxán‐Delgado, B., Parejo-Alonso, B., & Sancho, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00203 · Cited by 151
Wnt/β-Catenin Signaling in Liver Cancers
Wang, W., Smits, R., Hao, H., & He, C. (2019) · Cancers · doi:10.3390/cancers11070926 · Cited by 143
Metabolic reprogramming and its clinical implication for liver cancer
Yang, F., Hilakivi-Clarke, L. A., Shaha, A., Wang, Y., Wang, X., Deng, Y., Lai, J., & Kang, N. (2023) · Hepatology · doi:10.1097/hep.0000000000000005 · Cited by 140
Wnt Signaling in Cancer Metabolism and Immunity
El‐Sahli, S., Xie, Y., Wang, L., & Liu, S. (2019) · Cancers · doi:10.3390/cancers11070904 · Cited by 123
Temporal analyses of postnatal liver development and maturation by single-cell transcriptomics
Liang, Y., Kaneko, K., Xin, B., Lee, J., Sun, X., Zhang, K., & Feng, G.-S. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.01.004 · Cited by 116
Self-citationCancer stemness in hepatocellular carcinoma: mechanisms and translational potential
Tsui, Y., Chan, L., & Ng, I. O. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0823-9 · Cited by 119
Katoh, Y., Yaguchi, T., Kubo, A., Iwata, T., Morii, K., Kato, D., Ohta, S., Satomi, R., Yamamoto, Y., Oyamada, Y., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004616 · Cited by 115
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer
Wong, T. L., Loh, J.-J., Lu, S., Yan, H. H. N., Siu, H. C., Ren, X., Chan, D., Kam, M. J., Zhou, L., Tong, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38581-8 · Cited by 115
Ma, X., Sun, Y., Wang, B., Shen, M., Zhou, Y., Chen, J., Hu, B., Gong, Z., Zhang, X., Cao, Y., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5963-z · Cited by 108
Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis
Astuti, Y., Raymant, M., Quaranta, V., Clarke, K., Abudula, M., Smith, O., Bellomo, G., Chandran-Gorner, V., Nourse, C., Halloran, C. M., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00731-2 · Cited by 115
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives
Wang, W., Bai, L., Li, W., & Cui, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.605154 · Cited by 106
Pathogenesis of Alcohol-Associated Liver Disease
Osna, N. A., Rasineni, K., Ganesan, M., Donohue, T. M., & Kharbanda, K. K. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.05.004 · Cited by 99
Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma
Zhang, L., Li, X.-M., Shi, X.-H., Ye, K., Fu, X., Wang, X., Guo, S.-M., Ma, J., Xu, F., Sun, H., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00981-9 · Cited by 91
Wei, G., An, P., Vaid, K. A., Nasser, I., Huang, P., Tan, L., Zhao, S., Schuppan, D., & Popov, Y. V. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00041.2019 · Cited by 84
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Foglia, B., Beltrà, M., Sutti, S., & Cannito, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087463 · Cited by 82
Targeting cell-intrinsic metabolism for antifibrotic therapy
Gilgenkrantz, H., Mallat, A., Moreau, R., & Lotersztajn, S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.012 · Cited by 76
Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis
Wang, J., Li, L., Li, L., Qi, Y., Li, J., & Xu, T. (2018) · Gene · doi:10.1016/j.gene.2018.06.053 · Cited by 80
Self-citationDucheix, S., Peres, C., Härdfeldt, J., Frau, C., Mocciaro, G., Piccinin, E., Lobaccaro, J. A., Santis, S. D., Chieppa, M., Bertrand‐Michel, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.032 · Cited by 76
Self-citationBhattacharya, D., Basta, B. N., Mato, J. M., Craig, A. J., Fernández‐Ramos, D., Lopitz‐Otsoa, F., Tsvirkun, D., Hayardeny, L., Chandar, V., Schwartz, R. E., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100237 · Cited by 79
Stearoyl-CoA desaturase and tumorigenesis
Kikuchi, K., & Tsukamoto, H. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108917 · Cited by 75
Self-citationLiver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
Qu, W., Ma, T., Cai, J., Zhang, X., Zhang, P., She, Z., Wan, F., & Li, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.761538 · Cited by 71
Qin, X., Su, T., Yu, W., & Kojima, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2257-y · Cited by 64
Yao, Y., Sun, S., Wang, J., Fei, F., Dong, Z., Ke, A., He, R., Wang, L., Zhang, L., Ji, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3964 · Cited by 64
Self-citationFibrotic Events in the Progression of Cholestatic Liver Disease
Wu, H., Chen, C., Ziani, S., Nelson, L. J., Avila, M. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Cells · doi:10.3390/cells10051107 · Cited by 62
Eguchi, A., Yan, R., Pan, S. Q., Wu, R. P., Kim, J., Chen, Y., Ansong, C. K., Smith, R. D., Tempaku, M., Lucila Ohno-machado, A., et al. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01926-7 · Cited by 58
Self-citationMetabolic dependencies and targets in ovarian cancer
Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 65
Tao, L., Ma, W., Wu, L. C., Xu, M., Yang, Y., Zhang, W., Sha, W., Li, H., Xu, J., Feng, R., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317872 · Cited by 57
Self-citationThe role of tumor microenvironment on cancer stem cell fate in solid tumors
Razi, S., Haghparast, A., Khameneh, S. C., Sadrabadi, A. E., Aziziyan, F., Bakhtiyari, M., Nabi‐Afjadi, M., Tarhriz, V., Jalili, A., & Zalpoor, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01129-w · Cited by 56
Lin, J. B., Moolani, H. V., Sene, A., Sidhu, R., Kell, P., Lin, J. B., Dong, Z., Ban, N., Ory, D. S., & Apte, R. S. (2018) · JCI Insight · doi:10.1172/jci.insight.120157 · Cited by 54
RETRACTED ARTICLE: Circular RNA circStag1 promotes bone regeneration by interacting with HuR
Chen, G., Long, C., Wang, S., Wang, Z., Chen, X., Tang, W., He, X., Bao, Z., Tan, B., Zhao, J., et al. (2022) · Bone Research · doi:10.1038/s41413-022-00208-x · Cited by 52
RetractedJeong, W., & Jho, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714330 · Cited by 54
Niu, J., Li, W., Liang, C., Wang, X., Yao, X., Yang, R., Zhang, Z., Liu, F., Liu, F., Pei, S., et al. (2020) · Science Signaling · doi:10.1126/scisignal.abb5727 · Cited by 49
Qian, M., Hu, H., Yao, Y., Zhao, D., Wang, S., Pan, C., Duan, X., Gao, Y., Liu, J., Zhang, Y., et al. (2019) · Liver International · doi:10.1111/liv.14316 · Cited by 49
HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer
Liu, Y., Li, X., Zhang, H., Zhang, M., & Wei, Y. (2021) · Oncogene · doi:10.1038/s41388-021-01689-6 · Cited by 47
Lipid metabolism of cancer stem cells (Review)
Liu, H., Zhang, Z., Song, L., Gao, J., & Liu, Y. (2022) · Oncology Letters · doi:10.3892/ol.2022.13239 · Cited by 45
Bai, C., Luo, H., He, B., Liu, X., Lv, D., Zhang, X., Su, K., Zheng, S., Lü, J., Wang, C., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02159-1 · Cited by 47
Gajendiran, P., Vega, L., Itoh, K., Sesaki, H., Vakili, M., Lavasanifar, A., Hong, K., Mezey, E., & Ganapathy-Kanniappan, S. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13501 · Cited by 44
Yang, C. G., Wang, S., Ruan, H., Li, B., Cheng, Z., He, J., Zuo, Q., Yu, C., Wang, H., Lv, Y., et al. (2019) · Journal of Cancer · doi:10.7150/jca.27226 · Cited by 46
Leung, R. W. H., & Lee, T. K. (2022) · Cancers · doi:10.3390/cancers14215468 · Cited by 50
Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target
Zhao, Z., Cui, T., Wei, F., Zhou, Z., Sun, Y., Gao, C., Xu, X., & Zhang, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1367364 · Cited by 47
Human antigen R: A potential therapeutic target for liver diseases
Liu, R., Wu, K., Li, Y., Sun, R., & Li, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104684 · Cited by 43
Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways
Khan, F., Elsori, D. H., Verma, M., Pandey, S., Rab, S. O., Siddiqui, S., Alabdallah, N. M., Saeed, M., & Pandey, P. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1399065 · Cited by 45
The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy
Milella, M., Rutigliano, M., Pandolfo, S. D., Aveta, A., Crocetto, F., Ferro, M., d’Amati, A., Ditonno, P., Lucarelli, G. T., & Lasorsa, F. M. (2025) · Cells · doi:10.3390/cells14100717 · Cited by 46
Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in Cancer
Scott, J. S., Nassar, Z. D., Swinnen, J. V., & Butler, L. M. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-1069 · Cited by 42
Guo, F., Estévez‐Vázquez, O., Benedé‐Ubieto, R., Maya‐Miles, D., Zheng, K., Gallego‐Durán, R., Rojas, Á., Ampuero, J., Romero‐Gómez, M., Kaye, P., et al. (2021) · Cancers · doi:10.3390/cancers14010192 · Cited by 39
Dong, X., Wang, F., Liu, C., Jing, L., Jia, X., Shen, F., Yang, N., Zhu, S., Zhong, L., & Li, Q. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00403-5 · Cited by 39
The altered lipidome of hepatocellular carcinoma
Tan, S. L. W., Israeli, E., Ericksen, R. E., Chow, P. K. H., & Han, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.004 · Cited by 37
Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment
Bao, L., Xu, T., Lu, X., Huang, P. C., Pan, Z., & Ge, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.773028 · Cited by 37
Unveiling the MUFA–Cancer Connection: Insights from Endogenous and Exogenous Perspectives
Guo, Z., Bergeron, K., Lingrand, M., & Mounier, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129921 · Cited by 37
Skrypek, K., Balog, S., Eriguchi, Y., & Asahina, K. (2021) · Pancreas · doi:10.1097/mpa.0000000000001737 · Cited by 33
The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
Wang, K., Qiu, X., Zhao, Y., Wang, H., & Chen, L. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0306 · Cited by 32
Wnt lipidation: Roles in trafficking, modulation, and function
Hosseini, V., Dani, C., Geranmayeh, M. H., Mohammadzadeh, F., Ahmad, S. N. S., & Darabi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27570 · Cited by 30
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
Du, J., & Qin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367981 · Cited by 31
Gu, X., Sun, R., Chen, L., Chu, S., Doll, M. A., Li, X., Feng, W., Siskind, L. J., McClain, C. J., & Deng, Z. (2020) · Hepatology · doi:10.1002/hep.31628 · Cited by 28
Kabe, Y., Koike, I., Yamamoto, T., Hirai, M., Kanai, A., Furuhata, R., Tsugawa, H., Harada, E., Sugase, K., Hanadate, K., et al. (2021) · Cancers · doi:10.3390/cancers13133265 · Cited by 28
Self-citationCancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
Quiroz-Reyes, A. G., Lozano-Sepúlveda, S. A., Martínez-Acuña, N., Islas, J. F., González, P. D., Heredia-Torres, T. G., Roacho-Pérez, J. A., & Garza-Treviño, E. N. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231163677 · Cited by 31
Tian, H., Niu, H., Luo, J., Yao, W., Chen, X., Wu, J., Geng, Y., Gao, W., Lei, A., Gao, Z., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00642 · Cited by 28
Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma
Raeisi, M., Hassanbeigi, L., Khalili, F., Kharrati‐Shishavan, H., Yousefi, M., & Mehdizadeh, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07094-2 · Cited by 28
Mao, X., Tey, S. K., Ko, F. C. F., Kwong, E. M. L., Gao, Y., Ng, I. O., Cheung, S., Guan, X., & Yam, J. W. P. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.12.003 · Cited by 28
Cavallero, S., Roustaei, M., Satta, S., Cho, J. M., Phan, H., Baek, K. I., Blázquez‐Medela, A. M., Gonzalez-Ramos, S., Vu, K., Park, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj7481 · Cited by 27
Lee, H., Park, S., Lee, J. W., Lee, C., Kang, H., Kang, J., Lee, J. S., Shin, E., Youn, H., & Youn, B. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01081-6 · Cited by 31
Self-citationHu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors
Lachiondo‐Ortega, S., Delgado, T. C., Baños‐Jaime, B., Velázquez‐Cruz, A., Díaz‐Moreno, I., & Martínez‐Chantar, M. L. (2022) · Cancers · doi:10.3390/cancers14112666 · Cited by 27
Advances in regulation and function of stearoyl-CoA desaturase 1 in cancer, from bench to bed
Guo, Z., Huo, X., Li, X., Jiang, C., & Xue, L. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2352-9 · Cited by 28
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma
Allard, B., Jacoberger-Foissac, C., Cousineau, I., Barèche, Y., Buisseret, L., Chrobák, P., Allard, D., Pommey, S., Ah-Pine, F., Duquenne, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101188 · Cited by 27
Insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and Porcupine
Cabrae, R., Dubuquoy, C., Caüzac, M., Morzyglod, L., Guilmeau, S., Noblet, B., Fève, B., Postic, C., Burnol, A., & Moldes, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61869-4 · Cited by 26
CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2
Feng, D., Yan, K., Liang, H., Liang, J., Wang, W., Yu, H., Zhou, Y. Y., Zhao, W., Dong, Z., & Ling, B. (2020) · Neoplasia · doi:10.1016/j.neo.2020.10.013 · Cited by 26
The role of Evi/Wntless in exporting Wnt proteins
Wolf, L., & Boutros, M. (2023) · Development · doi:10.1242/dev.201352 · Cited by 28
Lin, Z., Hua, G., & Hu, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03481-4 · Cited by 31
Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy
Din, Z. U., Cui, B., Wang, C., Zhang, X., Mehmood, A., Peng, F., & Liu, Q. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04995-1 · Cited by 26
Calotropis gigantea stem bark extracts inhibit liver cancer induced by diethylnitrosamine
Sawong, S., Pekthong, D., Suknoppakit, P., Winitchaikul, T., Kaewkong, W., Somran, J., Intapa, C., Parhira, S., & Srisawang, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-16321-0 · Cited by 24
A Lipidomic Signature Complements Stemness Features Acquisition in Liver Cancer Cells
Rivas‐Serna, I. M., Romito, I., Maugeri, A., Re, O. L., Giallongo, S., Mazzoccoli, G., Oben, J. A., Volti, G. L., Mazza, T., Alisi, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228452 · Cited by 23
Gandouling inhibits hepatic fibrosis in Wilson's disease through Wnt-1/β-catenin signaling pathway
Cheng, C., Wang, Q., Huang, Y., Xue, Q., Wang, Y., Wu, P., Liao, F., & Miao, C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116445 · Cited by 24
NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling
Sunami, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186799 · Cited by 24
CMTM6 as a master regulator of PD-L1
Yaseen, M. M., Abuharfeil, N. M., & Darmani, H. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03171-y · Cited by 25
Abnormal lipid synthesis as a therapeutic target for cancer stem cells
Wang, S., Hu, Q., Wu, T., Xia, J., Tao, X., & Cheng, B. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i2.146 · Cited by 21
Mondal, S. A., Sathiaseelan, R., Mann, S. N., Kamal, M., Luo, W., Saccon, T. D., Isola, J. V. V., Peelor, F. F., Li, T., Freeman, W. M., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00256.2022 · Cited by 20
Su, T., Qin, X., Dohmae, N., Wei, F., Furutani, Y., Kojima, S., & Yu, W. (2021) · Metabolites · doi:10.3390/metabo11030167 · Cited by 18
Liver Steatosis: A Marker of Metabolic Risk in Children
Neri, C. R., Scapaticci, S., Chiarelli, F., & Giannini, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094822 · Cited by 23
Zhou, Z., Guo, C., Sun, X., Ren, Z., & Tao, J. (2023) · Stem Cells International · doi:10.1155/2023/4980871 · Cited by 18
Sinha, S., Aizawa, S., Nakano, Y., Rialdi, A., Choi, H. Y., Shrestha, R., Pan, S. Q., Chen, Y., Li, M., Kapelanski‐Lamoureux, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38406-8 · Cited by 19
Self-citationAhmad, S., Ali, S., Rehman, D. A. U., Haq, I. U., Liaqat, I., Aftab, M. N., & Shume, T. (2026) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002117 · Cited by 21
Metadata
- Authors
- Lai, K. K. Y., Kweon, S.-M., Chi, F., Hwang, E., Kabe, Y., Higashiyama, R., Qin, L., Yan, R., Wu, R. P., Lai, K., Fujii, N., French, S., Xu, J., Wang, J.-Y., Murali, R., Mishra, L., Lee, J.-S., Ntambi, J. M., & Tsukamoto, H.
- Affiliations
- University of Southern California (US)
- Keio University (JP)
- St. Jude Children's Research Hospital (US)
- University of Maryland, Baltimore (US)
- George Washington University (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Tsukamoto, Hidekazu
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 152
- Issue
- 6
- Pages
- 1477-1491
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC5406249
- OpenAlex
- W2582893389
- Cited by
- 165
- References
- 41
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 12 · 2023: 30 · 2022: 30 · 2021: 20 · 2020: 21 · 2019: 15 · 2018: 17 · 2017: 1
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (P50AA011999, R24AA12885, U01AA018663)
- American Cancer Society (IRG-58-007-54, R01DK062388)
- U.S. Department of Agriculture (W2005)
- U.S. Department of Veterans Affairs (5I01BX001991)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- liver fibrosis, hepatocellular carcinoma, Wnt signaling, LRP5, LRP6, monounsaturated fatty acids, hepatic stellate cells, cancer stem cells, HuR, mRNA stabilization, β-catenin, SREBP1, tumor self-renewal
- MeSH terms
- ELAV-Like Protein 1, Animals, Cholestasis, Diethylnitrosamine, Fatty Acids, Monounsaturated, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Male, Neoplasm Staging, Neoplasm Transplantation, RNA, Messenger, Stearoyl-CoA Desaturase, Transcription, Genetic, Neoplastic Stem Cells, Survival Rate, Case-Control Studies, Rats, Wistar, ran GTP-Binding Protein, beta Karyopherins, Cell Line, Tumor, beta Catenin, Mice, Rats, Sterol Regulatory Element Binding Protein 1, Hepatic Stellate Cells, Wnt Signaling Pathway, Low Density Lipoprotein Receptor-Related Protein-6, Low Density Lipoprotein Receptor-Related Protein-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
